Literature DB >> 2563933

Regional cerebral blood flow in depression and mania.

P Silfverskiöld1, J Risberg.   

Abstract

Forty-three depressed inpatients, referred for electroconvulsive therapy, and 30 manic patients were examined with clinical ratings and regional cerebral blood flow (rCBF) determinations. The depressed patients were mainly medication free, while most of the manic patients were medicated. Both patient groups showed a normal cerebral blood flow level and regional distribution compared with age- and sex-matched normal controls. In the depressed group and especially in the unipolar subgroup, a significant positive relationship was found between the mean rCBF and symptoms of depression and cognitive dysfunction. Eighteen of the depressed and 18 of the manic patients were reexamined in a euthymic state following treatment and recovery. Only minor and statistically nonsignificant flow changes were found in connection with the clinical improvement. In the manic patients, a significant negative relationship was found between neuroleptic dosage and rCBF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563933     DOI: 10.1001/archpsyc.1989.01810030059008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  15 in total

Review 1.  [Value of diagnostic imaging in evaluation of electroconvulsive therapy].

Authors:  T Frodl; E M Meisenzahl; H-J Möller
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

2.  Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Authors:  Charles R Conway; Yvette I Sheline; John T Chibnall; Richard D Bucholz; Joseph L Price; Sunil Gangwani; Mark A Mintun
Journal:  Brain Stimul       Date:  2011-04-03       Impact factor: 8.955

3.  Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Authors:  Charles R Conway; John T Chibnall; Sunil Gangwani; Mark A Mintun; Joseph L Price; Tamara Hershey; Luis A Giuffra; Richard D Bucholz; Jon J Christensen; Yvette I Sheline
Journal:  J Affect Disord       Date:  2012-03-05       Impact factor: 4.839

Review 4.  Functional neuroimaging in psychiatry.

Authors:  C H Fu; P K McGuire
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

5.  Schizophrenia and bipolar disorder are distinguished mainly by differences in neurodevelopment.

Authors:  Jenny Walker; Vivienne Curtis; Philip Shaw; Robin M. Murray
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

6.  Assessment of changes in regional cerebral blood flow in patients with major depression using the 99mTc-HMPAO single photon emission tomography method.

Authors:  K M Yazici; O Kapucu; B Erbas; E Varoglu; C Gülec; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1992

7.  HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.

Authors:  Sven E Pålhagen; Stefan Ekberg; Jan Wålinder; Ann-Kathrine Granérus; Göran Granerus
Journal:  J Neurol       Date:  2009-05-10       Impact factor: 4.849

Review 8.  Emotional behavior as an agenda in neuropsychological evaluation.

Authors:  A G Sherman; T G Shaw; H Glidden
Journal:  Neuropsychol Rev       Date:  1994-03       Impact factor: 7.444

9.  Cerebral haemodynamics and depression in the elderly.

Authors:  H Tiemeier; S L M Bakker; A Hofman; P J Koudstaal; M M B Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-07       Impact factor: 10.154

10.  Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.

Authors:  Daniel Mamah; Jie Wen; Jie Luo; Xialing Ulrich; Deanna M Barch; Dmitriy Yablonskiy
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.